Delivery Order SPE2DB20D1100-SPE2DB25FD6F9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.19 firm fixed-price contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period ending on December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,740.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical procurement operations, which support military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.06 firm fixed-price delivery order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has a ceiling value of $1,974.40 and a performance period ending on May 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a $2,707.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and other federal healthcare programs. The award is not associated with a set-aside program. AmerisourceBergen holds...
- This is a $3,971.18 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with an ultimate completion date of May 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.63, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 4, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor,...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,336.48 firm-fixed-price contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of May 14, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM to the Defense Logistics Agency (DLA), a defense agency. The $6,777.33 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, without any set-aside designation. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6F9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of pharmaceuticals, medical devices, and healthcare commodities. The company's extensive federal contracting portfolio demonstrates consistent capability to fulfill military and veteran healthcare supply requirements through competitive awards. This delivery order exemplifies the company's role in supporting DLA's Medical Supply Chain with essential medications and medical supplies across multiple therapeutic domains to sustain military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/24/25 |